Prudent Man Advisors LLC Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Prudent Man Advisors LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.4% during the first quarter, HoldingsChannel.com reports. The fund owned 2,001 shares of the healthcare conglomerate’s stock after selling 71 shares during the quarter. Prudent Man Advisors LLC’s holdings in UnitedHealth Group were worth $1,020,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. Capital Advisors Ltd. LLC grew its holdings in UnitedHealth Group by 13.6% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,333 shares of the healthcare conglomerate’s stock valued at $680,000 after purchasing an additional 160 shares in the last quarter. Lake Street Financial LLC grew its holdings in UnitedHealth Group by 10.3% during the 1st quarter. Lake Street Financial LLC now owns 2,860 shares of the healthcare conglomerate’s stock worth $1,459,000 after acquiring an additional 266 shares in the last quarter. Banco Santander S.A. grew its holdings in UnitedHealth Group by 7.0% during the 1st quarter. Banco Santander S.A. now owns 102,174 shares of the healthcare conglomerate’s stock worth $52,106,000 after acquiring an additional 6,687 shares in the last quarter. Lindenwold Advisors grew its holdings in UnitedHealth Group by 1.8% during the 1st quarter. Lindenwold Advisors now owns 9,919 shares of the healthcare conglomerate’s stock worth $5,058,000 after acquiring an additional 172 shares in the last quarter. Finally, Hartford Funds Management Co LLC acquired a new position in UnitedHealth Group during the 1st quarter worth $295,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $535.06 on Friday. The firm’s 50 day moving average is $506.46 and its 200-day moving average is $499.44. The stock has a market capitalization of $500.48 billion, a P/E ratio of 27.94, a P/E/G ratio of 1.65 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same period last year, the firm posted $4.70 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.86 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were given a $1.65 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a dividend yield of 1.23%. The ex-dividend date of this dividend was Thursday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 34.46%.

Analyst Ratings Changes

UNH has been the topic of a number of recent research reports. Cowen raised their price target on shares of UnitedHealth Group from $512.00 to $596.00 in a research report on Monday, April 18th. BMO Capital Markets raised their price target on shares of UnitedHealth Group from $600.00 to $610.00 in a research report on Wednesday, July 20th. Loop Capital assumed coverage on shares of UnitedHealth Group in a research report on Thursday, June 16th. They issued a “buy” rating and a $575.00 price objective on the stock. Royal Bank of Canada set a $563.00 price objective on shares of UnitedHealth Group and gave the company an “outperform” rating in a research report on Monday, April 18th. Finally, SVB Leerink lifted their price objective on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $582.50.

Insider Activity at UnitedHealth Group

In related news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO John F. Rex sold 13,183 shares of UnitedHealth Group stock in a transaction that occurred on Friday, July 29th. The shares were sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the completion of the sale, the chief financial officer now owns 141,508 shares of the company’s stock, valued at $76,630,827.24. The disclosure for this sale can be found here. Over the last three months, insiders have sold 130,144 shares of company stock valued at $69,269,555. Corporate insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.